Correlation Between Catalyst Pharmaceuticals and Ardelyx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Ardelyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Ardelyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and Ardelyx, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Ardelyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Ardelyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Ardelyx.

Diversification Opportunities for Catalyst Pharmaceuticals and Ardelyx

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between Catalyst and Ardelyx is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Ardelyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ardelyx and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Ardelyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ardelyx has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Ardelyx go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and Ardelyx

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 78.18 times less return on investment than Ardelyx. But when comparing it to its historical volatility, Catalyst Pharmaceuticals is 1.9 times less risky than Ardelyx. It trades about 0.01 of its potential returns per unit of risk. Ardelyx is currently generating about 0.4 of returns per unit of risk over similar time horizon. If you would invest  491.00  in Ardelyx on November 22, 2024 and sell it today you would earn a total of  151.00  from holding Ardelyx or generate 30.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Catalyst Pharmaceuticals  vs.  Ardelyx

 Performance 
       Timeline  
Catalyst Pharmaceuticals 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Ardelyx 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Ardelyx are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Ardelyx showed solid returns over the last few months and may actually be approaching a breakup point.

Catalyst Pharmaceuticals and Ardelyx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Catalyst Pharmaceuticals and Ardelyx

The main advantage of trading using opposite Catalyst Pharmaceuticals and Ardelyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Ardelyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ardelyx will offset losses from the drop in Ardelyx's long position.
The idea behind Catalyst Pharmaceuticals and Ardelyx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments